Achieving efficient RNAi therapy: progress and challenges
Authors:
- Kun GaoKGKun Gao
- Leaf HuangLHLeaf Huang
Open Access
- 1 July 2013
- journal article
- review article
- Published by Elsevier in Acta Pharmaceutica Sinica B
- Vol. 3 (4) , 213-225
Abstract
No abstract availableKeywords
Funding Information
- NIH (CA129835, CA129421, CA149363, CA151652)
This publication has 161 references indexed in Scilit:
- Stability of lyophilized siRNA nanosome formulationsInternational Journal of Pharmaceutics, 2012
- Unconventional internalization mechanisms underlying functional delivery of antisense oligonucleotides via cationic lipoplexes and polyplexesJournal of Controlled Release, 2011
- Co-delivery of small interfering RNA and plasmid DNA using a polymeric vector incorporating endosomolytic oligomeric sulfonamideBiomaterials, 2011
- Enzyme‐synthesized poly(amine‐co‐esters) as nonviral vectors for gene deliveryJournal of Biomedical Materials Research Part A, 2010
- Chlorotoxin bound magnetic nanovector tailored for cancer cell targeting, imaging, and siRNA deliveryBiomaterials, 2010
- Drug delivery systems: Advanced technologies potentially applicable in personalized treatmentsEPMA Journal, 2010
- Gene Regulation with Polyvalent siRNA−Nanoparticle ConjugatesJournal of the American Chemical Society, 2009
- Lung Delivery Studies Using siRNA Conjugated to TAT(48−60) and Penetratin Reveal Peptide Induced Reduction in Gene Expression and Induction of Innate ImmunityBioconjugate Chemistry, 2007
- RNAi therapeutics: Principles, prospects and challengesAdvanced Drug Delivery Reviews, 2007
- RNA Interference in Mammalian Cells by Chemically-Modified RNABiochemistry, 2003